GE wants on the T-wave
This article was originally published in The Gray Sheet
Executive Summary
CMS accepts GE Healthcare's request Aug. 17 to consider national coverage of its Marquette modified moving average (MMA) microvolt T-wave alternans test. MTWA tests are used to risk stratify patients for cardioverter defibrillator implants. Based on lack of evidence, a March 2006 CMS coverage decision excludes the MMA method - cleared for risk stratification in 2003 - and only covers Cambridge Heart's HearTwave II test, which uses a proprietary spectral analysis algorithm (1"The Gray Sheet" March 27, 2006, p. 18). GE says studies published in 2007 show MMA's equivalence to the spectral method. CMS is accepting initial comments on the reconsideration until Sept. 17 and will issue a proposed decision by Feb. 17...
You may also be interested in...
Heart Rhythm Society, Doctors Oppose National Coverage Of GE’s MTWA Test
GE Healthcare and Cambridge Heart are squaring off over rival methods of microvolt T-wave alternans testing
Medicare In Brief
MTWA covered: Cambridge Heart receives national coverage for its Heartwave II Microvolt T-Wave Alternans test March 21. The non-invasive test can identify patients who are unlikely to benefit from an implantable cardioverter defibrillator. ICD manufacturers, who argued against coverage during the public comment period, fear that the final decision represents an attempt by CMS to cut Medicare costs by reducing the ICD candidate population. The final coverage determination echoes CMS' Dec. 21 proposed decision, which requires use of Cambridge Heart's patented analytic spectral algorithm, but does not mandate MTWA testing for a patient to be eligible for an ICD (1"The Gray Sheet" Jan. 2, 2006, p. 6). Because General Electric's Marquette T-Wave Alternans device relies on a different algorithm than Cambridge Heart's, CMS says that all local carriers covering GE's device must halt coverage until the firm applies for an NCD...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.